EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Noninvasive prenatal diagnosis of Mendelian disorders for consanguineous couples by relative genotype dosage

Siv Fokstuen iD, Lina Quteineh, Valérie M Schwitzgebel iD, Bettina Köhler-Ballan, Jean-Louis Blouin iD, Marc Abramowicz iD, Thierry Nouspikel iD

Clinical Genetics · 2023

DOI: 10.1111/cge.14399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2023. Verfasst von Siv Fokstuen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Genetic Medicine, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Noninvasive Prenatal Testing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Noninvasive prenatal diagnosis relies on the presence in maternal blood of circulating cell‐free fetal DNA released by apoptotic trophoblast cells. Widely used for aneuploidy screening, it can also be applied to monogenic diseases (NIPD‐M) in case of known parental mutations. Due to the confounding effect of maternal DNA, detection of maternal or biparental mutations requires relative haplotype dosage (RHDO), a method relying on the presence of SNPs that are heterozygous in one parent and homozygous in the other. Unavoidably, there is a risk of test failure by lack of such informative SNPs, an event particularly likely for consanguineous couples who often share common haplotypes in regions of identity‐by‐descent. Here we present a novel approach, relative genotype dosage (RGDO) that bypasses this predicament by directly assessing fetal genotype with SNPs that are heterozygous in both parents (frequent in regions of identity‐by‐descent). We show that RGDO is as sensitive as RHDO and that it performs well over a large range of fetal fractions and DNA amounts, thereby opening NIPD‐M to most consanguineous couples. We also report examples of couples, consanguineous or not, where combining RGDO and RHDO allowed a diagnosis that would not have been possible with only one approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noninvasive Prenatal TestingPregnancyFemaleHumansPrenatal DiagnosisConsanguinityGenotypeDNA

Stichwörter der Autor:innen

cell-free circulating DNAconsanguinityfetal DNAmonogenic diseasenoninvasive prenatal diagnosis

Substanzen

DNA

Autor:innen und Institutionen

  • Genetic Medicine, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland.
  • Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Pediatric Endocrine and Diabetes Unit, Department of Pediatrics, Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland.
  • Diabetes Center of the Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Department of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland.

ORCID-Profile: Siv Fokstuen, Valérie M Schwitzgebel, Jean-Louis Blouin, Marc Abramowicz, Thierry Nouspikel

Zitieren

APA

Fokstuen, S., Quteineh, L., Schwitzgebel, V. M., Köhler-Ballan, B., Blouin, J. L., Abramowicz, M., & Nouspikel, T. (2023). Noninvasive prenatal diagnosis of Mendelian disorders for consanguineous couples by relative genotype dosage. Clinical Genetics. https://doi.org/10.1111/cge.14399

Vancouver

Fokstuen S, Quteineh L, Schwitzgebel VM, Köhler-Ballan B, Blouin JL, Abramowicz M, et al. Noninvasive prenatal diagnosis of Mendelian disorders for consanguineous couples by relative genotype dosage. Clinical Genetics. 2023. doi:10.1111/cge.14399

BibTeX
@article{Fokstuen2023,
  author = {Fokstuen, Siv and Quteineh, Lina and Schwitzgebel, Valérie M and Köhler-Ballan, Bettina and Blouin, Jean-Louis and Abramowicz, Marc and Nouspikel, Thierry},
  title = {Noninvasive prenatal diagnosis of Mendelian disorders for consanguineous couples by relative genotype dosage},
  journal = {Clinical Genetics},
  year = {2023},
  doi = {10.1111/cge.14399}
}
Kostenlos starten →